Hepatitis C in HIV‐infected individuals: a systematic review and meta‐analysis of estimated prevalence in Africa
Open Access
- 1 January 2016
- journal article
- research article
- Published by Wiley in Journal of the International AIDS Society
- Vol. 19 (1) , 20711
Abstract
Introduction: Although hepatitis C virus (HCV) screening is recommended for all HIV‐infected patients initiating antiretroviral therapy, data on epidemiologic characteristics of HCV infection in resource‐limited settings are scarce.Methods: We searched PubMed and EMBASE for studies assessing the prevalence of HCV infection among HIV‐infected individuals in Africa and extracted data on laboratory methods used. Prevalence estimates from individual studies were combined for each country using random‐effects meta‐analysis. The importance of study design, population and setting as well as type of test (anti‐HCV antibody tests and polymerase chain reactions) was examined with meta‐regression.Results: Three randomized controlled trials, 28 cohort studies and 121 cross‐sectional analyses with 108,180 HIV‐infected individuals from 35 countries were included. The majority of data came from outpatient populations (55%), followed by blood donors (15%) and pregnant women (14%). Based on estimates from 159 study populations, anti‐HCV positivity prevalence ranged between 3.3% (95% confidence interval (CI) 1.8–4.7) in Southern Africa and 42.3% (95% CI 4.1–80.5) in North Africa. Study design, type of setting and age distribution did not influence this prevalence significantly. The prevalence of replicating HCV infection, estimated from data of 29 cohorts, was 2.0% (95% CI 1.5–2.6). Ten studies from nine countries reported the HCV genotype of 74 samples, 53% were genotype 1, 24% genotype 2, 14% genotype 4 and 9% genotypes 3, 5 or 6.Conclusions: The prevalence of anti‐HCV antibodies is high in HIV‐infected patients in Africa, but replicating HCV infection is rare and varies widely across countries.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (5U01-AI069924-05)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
This publication has 27 references indexed in Scilit:
- PROSPERO at one year: an evaluation of its utilitySystematic Reviews, 2013
- Prevalence of hepatitis C virus infection among human immunodeficiency virus-1-infected pregnant women in Malawi: The BAN studyJournal of Clinical Virology, 2012
- Expanding Access to Treatment for Hepatitis C in Resource-Limited Settings: Lessons From HIV/AIDSClinical Infectious Diseases, 2012
- Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviewsThe Lancet, 2011
- Geostatistical Model-Based Estimates of Schistosomiasis Prevalence among Individuals Aged ≤20 Years in West AfricaPLOS Neglected Tropical Diseases, 2011
- Liver-Related Deaths in Persons Infected With the Human Immunodeficiency VirusArchives of internal medicine (1960), 2006
- Prevalence of Low Positive Anti-HCV Antibodies in Blood Donors:Schistosoma mansoniCo-Infection and Possible Role of AutoantibodiesMicrobiology and Immunology, 2006
- Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studiesJournal of Viral Hepatitis, 2005
- A Modified Poisson Regression Approach to Prospective Studies with Binary DataAmerican Journal of Epidemiology, 2004
- Virus, liver and autoimmunityDigestive and Liver Disease, 2000